ICU MEDICAL INC/DE (ICUI)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 250M 500M 750M Q3 '21: 336.1M Q4 '21: 340.5M Q1 '22: 543.1M Q2 '22: 561M Q3 '22: 597.9M Q4 '22: 578M Q1 '23: 568.6M Q2 '23: 549.3M Q3 '23: 553.3M Q4 '23: 587.9M Q1 '24: 566.7M Q2 '24: 596.5M Q3 '24: 589.1M Q4 '24: 629.8M Q1 '25: 604.7M Q2 '25: 548.9M Q3 '25: 537M Q4 '25: 540.7M Q1 '26: 530.2M Q2 '26: 551.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 80M 160M 240M Q3 '21: 127.8M Q4 '21: 127.5M Q1 '22: 168.8M Q2 '22: 167.6M Q3 '22: 186.4M Q4 '22: 174.9M Q1 '23: 192M Q2 '23: 192.3M Q3 '23: 183.9M Q4 '23: 171.6M Q1 '24: 185.2M Q2 '24: 207.4M Q3 '24: 204.9M Q4 '24: 227.3M Q1 '25: 210.1M Q2 '25: 208.1M Q3 '25: 200.9M Q4 '25: 203M Q1 '26: 206.2M Q2 '26: 235.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

-45M -30M -15M 0 15M 30M 45M Q2 '21: 34.5M Q3 '21: 38.4M Q4 '21: 23.8M Q1 '22: -42.2M Q2 '22: -48K Q3 '22: -467K Q4 '22: -222K Q1 '23: 9.4M Q2 '23: 2.8M Q3 '23: 22.9M Q1 '24: -10.7M Q2 '24: 7.7M Q3 '24: 8.2M Q4 '24: 37.7M Q1 '25: 12.9M Q2 '25: 10.6M Q3 '25: 13.7M Q4 '25: 5.6M Q1 '26: 13.6M Q2 '26: 39.1M Q3 '21 Q2 '22 Q1 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-45M -30M -15M 0 15M 30M 45M Q3 '21: 31.1M Q4 '21: 19.9M Q1 '22: -38.1M Q2 '22: -7.5M Q3 '22: -9.8M Q4 '22: -18.9M Q1 '23: -9.8M Q2 '23: -9.9M Q3 '23: 7.2M Q4 '23: -17.1M Q1 '24: -39.5M Q2 '24: -21.4M Q3 '24: -33M Q4 '24: -23.8M Q1 '25: -15.5M Q2 '25: 35.3M Q3 '25: -3.4M Q4 '25: -15.7M Q1 '26: 30.1M Q2 '26: 19.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 150M 300M 450M Q3 '21: 208.3M Q4 '21: 213M Q1 '22: 374.3M Q2 '22: 393.4M Q3 '22: 411.5M Q4 '22: 403.1M Q1 '23: 376.6M Q2 '23: 357M Q3 '23: 369.4M Q4 '23: 416.3M Q1 '24: 381.4M Q2 '24: 389M Q3 '24: 384.3M Q4 '24: 402.5M Q1 '25: 394.6M Q2 '25: 340.8M Q3 '25: 336.1M Q4 '25: 337.7M Q1 '26: 324M Q2 '26: 316.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-70M -35M 0 35M 70M 105M Q3 '21: 78.8M Q4 '21: 82.6M Q1 '22: -1.3M Q2 '22: -61.4M Q3 '22: 2.3M Q4 '22: -1.7M Q1 '23: 41.2M Q2 '23: -1.5M Q3 '23: 35.2M Q4 '23: 91.3M Q1 '24: 45.8M Q2 '24: 82M Q3 '24: 36.1M Q4 '24: 40.2M Q1 '25: 51.3M Q2 '25: 11.2M Q3 '25: 56.7M Q4 '25: 60.6M Q1 '26: 38.9M Q2 '26: 80.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-90M -60M -30M 0 30M 60M 90M Q3 '21: 62.1M Q4 '21: 60.5M Q1 '22: -24.9M Q2 '22: -85.8M Q3 '22: -18.4M Q4 '22: -23.3M Q1 '23: 27M Q2 '23: -19.8M Q3 '23: 13.7M Q4 '23: 61.3M Q1 '24: 29.9M Q2 '24: 62.5M Q3 '24: 16.2M Q4 '24: 16.1M Q1 '25: 36.7M Q2 '25: -8.5M Q3 '25: 27.6M Q4 '25: 36M Q1 '26: 27.6M Q2 '26: 61.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 9M 18M 27M Q1 '20: 21.5M Q2 '20: 21.5M Q3 '20: 21.6M Q1 '21: 21.7M Q2 '21: 21.7M Q3 '21: 21.7M Q1 '22: 23.6M Q2 '22: 23.9M Q3 '22: 23.9M Q1 '23: 24M Q2 '23: 24.1M Q3 '23: 24.4M Q1 '24: 24.2M Q2 '24: 24.4M Q3 '24: 24.4M Q1 '25: 24.5M Q2 '25: 24.7M Q3 '25: 24.7M Q1 '26: 25.2M Q2 '26: 25M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-6.00 -4.00 -2.00 0.00 2.00 4.00 6.00 Q3 '21: 5.04 Q4 '21: 4.74 Q1 '22: 2.04 Q2 '22: 0.42 Q3 '22: -1.56 Q4 '22: -3.11 Q1 '23: -1.91 Q2 '23: -2.01 Q3 '23: -1.16 Q4 '23: -1.23 Q1 '24: -2.45 Q2 '24: -2.92 Q3 '24: -4.57 Q4 '24: -4.84 Q1 '25: -3.84 Q2 '25: -1.53 Q3 '25: -0.32 Q4 '25: 0.03 Q1 '26: 1.86 Q2 '26: 1.19 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.